Andrew J Lees Selected Research

Andrew J Lees Research Topics

Disease

99	Parkinson Disease (Parkinson's Disease) 01/2022 - 09/2002
38	Parkinsonian Disorders (Parkinsonism) 01/2021 - 10/2002
20	Dyskinesias (Dyskinesia) 09/2018 - 09/2002
16	Dementia (Dementias) 01/2021 - 09/2003
15	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2021 - 07/2003
10	Tremor (Tremors) 01/2021 - 04/2003
9	Cognitive Dysfunction 01/2020 - 09/2002
8	Dystonia (Limb Dystonia) 10/2020 - 12/2002
7	Multiple System Atrophy 01/2021 - 09/2009
7	Hypokinesia (Bradykinesia) 09/2016 - 03/2003
7	Alzheimer Disease (Alzheimer's Disease) 09/2016 - 07/2003
6	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 12/2021 - 09/2009
6	Hallucinations (Hallucination) 01/2021 - 09/2002
5	Gambling (Pathological Gambling) 11/2011 - 09/2007
4	Tauopathies 09/2016 - 04/2004
4	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 11/2012 - 09/2009
3	Dysarthria (Spastic Dysarthria) 10/2020 - 09/2002
3	Synucleinopathies 01/2016 - 11/2010
3	Frontotemporal Dementia (Semantic Dementia) 08/2015 - 10/2006
3	Disease Progression 01/2014 - 04/2006
3	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2013 - 05/2007
3	Bulimia (Binge Eating) 11/2011 - 04/2010
3	Atrophy 06/2010 - 04/2006
2	Orthostatic Hypotension (Postural Hypotension) 01/2021 - 08/2015
2	Constipation 02/2017 - 06/2009
2	Psychotic Disorders (Schizoaffective Disorder) 08/2013 - 06/2003
2	Mania (Manias) 06/2011 - 04/2004
2	Essential Tremor (Essential Tremors) 04/2010 - 07/2007
2	Corticobasal Degeneration 10/2009 - 12/2008
2	Pain (Aches) 06/2009 - 03/2004
2	Substance-Related Disorders (Drug Abuse) 01/2009 - 05/2006
2	Paralysis (Palsy) 10/2005 - 03/2003
2	Dystonic Disorders (Writer's Cramp) 04/2005 - 06/2003
2	Tic Disorders (Tic Disorder) 10/2004 - 07/2002
1	Urinary Incontinence 01/2021
1	Consciousness Disorders 01/2021
1	Brain Diseases (Brain Disorder) 10/2020
1	Infections 10/2020
1	Nervous System Diseases (Neurological Disorders) 11/2019
1	Inflammation (Inflammations) 01/2019
1	Type 2 Episodic Ataxia 01/2018

Drug/Important Bio-Agent (IBA)

48	Levodopa (L Dopa)FDA LinkGeneric 01/2022 - 09/2002
29	Dopamine (Intropin)FDA LinkGeneric 09/2018 - 10/2002
13	Dopamine Agonists (Dopamine Agonist)IBA 01/2016 - 09/2002
12	Proteins (Proteins, Gene)FDA Link 03/2017 - 07/2003
10	SynucleinsIBA 01/2020 - 09/2007
10	Apomorphine FDA Link 12/2018 - 09/2002
7	alpha-SynucleinIBA 01/2016 - 02/2004
7	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 06/2015 - 10/2004
6	Biomarkers (Surrogate Marker)IBA 01/2019 - 02/2009
6	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 06/2015 - 12/2002
6	Dopamine Agents (Dopaminergic Agents)IBA 02/2013 - 09/2002
6	Pharmaceutical PreparationsIBA 09/2011 - 07/2004
5	Cholinergic Agents (Cholinergics)IBA 01/2021 - 03/2004
5	Dihydroxyphenylalanine (Dopa)IBA 09/2018 - 10/2002
5	Protein Isoforms (Isoforms)IBA 11/2012 - 02/2004
5	UbiquitinIBA 09/2011 - 07/2003
4	opicaponeIBA 01/2022 - 02/2017
4	Amyloid (Amyloid Fibrils)IBA 01/2016 - 05/2011
4	RacloprideIBA 06/2015 - 06/2004
4	Leucine (L-Leucine)FDA Link 09/2012 - 01/2005
4	Phosphotransferases (Kinase)IBA 09/2012 - 01/2005
3	IronIBA 01/2021 - 06/2010
3	entacapone (Comtan)FDA Link 01/2018 - 09/2004
3	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 02/2017 - 01/2008
3	Antipsychotic Agents (Antipsychotics)IBA 09/2016 - 07/2002
3	Glucosylceramidase (Glucocerebrosidase)IBA 02/2013 - 06/2009
3	AntibodiesIBA 11/2012 - 10/2004
3	fluorodopa F 18IBA 11/2009 - 09/2005
2	Dopamine D3 ReceptorsIBA 12/2021 - 11/2019
2	monomethylpropion (methcathinone)IBA 10/2020 - 04/2013
2	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 10/2020 - 11/2019
2	BenzodiazepinesIBA 01/2018 - 09/2016
2	Botulinum Toxins (Botulinum Toxin)IBA 09/2016 - 03/2004
2	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2016 - 04/2007
2	Amyloid beta-PeptidesIBA 01/2016 - 04/2008
2	tau Proteins (tau Protein)IBA 06/2014 - 09/2003
2	Tolcapone (Tasmar)FDA Link 01/2014 - 01/2008
2	RNA (Ribonucleic Acid)IBA 08/2011 - 01/2004
2	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 04/2011 - 06/2006
2	Proteasome Endopeptidase Complex (Proteasome)IBA 07/2010 - 04/2004
2	pregnancy-associated growth factorIBA 05/2008 - 06/2007
2	Dopamine Receptors (Dopamine Receptor)IBA 04/2008 - 02/2005
2	Peptides (Polypeptides)IBA 04/2008 - 07/2007
2	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 05/2007 - 08/2003
2	Messenger RNA (mRNA)IBA 10/2006 - 02/2004
2	Cholinergic Antagonists (Anticholinergics)IBA 08/2003 - 06/2003
1	naxagolideIBA 12/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021
1	Biological FactorsIBA 12/2020
1	Potassium PermanganateIBA 10/2020
1	Pseudoephedrine FDA LinkGeneric 10/2020
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2018

Therapy/Procedure

33	Therapeutics 01/2022 - 09/2002
3	Deep Brain Stimulation 01/2014 - 09/2009
3	Drug Therapy (Chemotherapy) 08/2011 - 05/2010
2	Subcutaneous Injections 10/2017 - 01/2016
2	Subcutaneous Infusions 01/2016 - 11/2002
2	Denervation 02/2010 - 03/2003
1	Urinary Catheters 01/2021